Why the study?
Is the presence of Papillary Muscle Infarction (PapMI) associated with worse outcomes in patients with reperfused ST-segment-elevation myocardial infarction?
Is the presence of Papillary Muscle Infarction (PapMI) associated with worse outcomes in patients with reperfused ST-segment-elevation myocardial infarction?
Papillary muscle infarction visualized by CMR serves as a significant marker of poor prognosis and increased MACE in patients with reperfused STEMI.
PapMI on CMR flags higher MACE risk in reperfused STEMI; hypothesis-generating and requires validation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eitel et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: